BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31664448)

  • 1. Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With Neuroinflammation.
    McCreary D; Omoyinmi E; Hong Y; Mulhern C; Papadopoulou C; Casimir M; Hacohen Y; Nyanhete R; Ahlfors H; Cullup T; Lim M; Gilmour K; Mankad K; Wassmer E; Berg S; Hemingway C; Brogan P; Eleftheriou D
    JAMA Netw Open; 2019 Oct; 2(10):e1914274. PubMed ID: 31664448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders.
    Montaut S; Tranchant C; Drouot N; Rudolf G; Guissart C; Tarabeux J; Stemmelen T; Velt A; Fourrage C; Nitschké P; Gerard B; Mandel JL; Koenig M; Chelly J; Anheim M;
    JAMA Neurol; 2018 Oct; 75(10):1234-1245. PubMed ID: 29913018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis.
    Omoyinmi E; Standing A; Keylock A; Price-Kuehne F; Melo Gomes S; Rowczenio D; Nanthapisal S; Cullup T; Nyanhete R; Ashton E; Murphy C; Clarke M; Ahlfors H; Jenkins L; Gilmour K; Eleftheriou D; Lachmann HJ; Hawkins PN; Klein N; Brogan PA
    PLoS One; 2017; 12(7):e0181874. PubMed ID: 28750028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective genotype-phenotype analysis in a 305 patient cohort referred for testing of a targeted epilepsy panel.
    Hesse AN; Bevilacqua J; Shankar K; Reddi HV
    Epilepsy Res; 2018 Aug; 144():53-61. PubMed ID: 29778030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Oculome Panel Test: Next-Generation Sequencing to Diagnose a Diverse Range of Genetic Developmental Eye Disorders.
    Patel A; Hayward JD; Tailor V; Nyanhete R; Ahlfors H; Gabriel C; Jannini TB; Abbou-Rayyah Y; Henderson R; Nischal KK; Islam L; Bitner-Glindzicz M; Hurst J; Valdivia LE; Zanolli M; Moosajee M; Brookes J; Papadopoulos M; Khaw PT; Cullup T; Jenkins L; Dahlmann-Noor A; Sowden JC
    Ophthalmology; 2019 Jun; 126(6):888-907. PubMed ID: 30653986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Next-Generation Sequencing for Molecular Diagnosis in Patients With Infantile Nystagmus Syndrome.
    Rim JH; Lee ST; Gee HY; Lee BJ; Choi JR; Park HW; Han SH; Han J
    JAMA Ophthalmol; 2017 Dec; 135(12):1376-1385. PubMed ID: 29145603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach.
    Alkorta-Aranburu G; Carmody D; Cheng YW; Nelakuditi V; Ma L; Dickens JT; Das S; Greeley SAW; Del Gaudio D
    Mol Genet Metab; 2014 Dec; 113(4):315-320. PubMed ID: 25306193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of targeted capture technology and next generation sequencing in molecular diagnosis of inherited myopathy].
    Fu X; Liu A; Yang H; Wei C; Ding J; Wang S; Wang J; Yuan Y; Jiang Y; Xiong H
    Zhonghua Er Ke Za Zhi; 2015 Oct; 53(10):741-6. PubMed ID: 26758109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic Centers.
    Elsink K; Huibers MMH; Hollink IHIM; Simons A; Zonneveld-Huijssoon E; van der Veken LT; Leavis HL; Henriet SSV; van Deuren M; van de Veerdonk FL; Potjewijd J; Berghuis D; Dalm VASH; Vermont CL; van de Ven AAJM; Lambeck AJA; Abbott KM; van Hagen PM; de Bree GJ; Kuijpers TW; Frederix GWJ; van Gijn ME; van Montfrans JM;
    Front Immunol; 2021; 12():780134. PubMed ID: 34992599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.
    Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F
    Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.
    Mansilla MA; Sompallae RR; Nishimura CJ; Kwitek AE; Kimble MJ; Freese ME; Campbell CA; Smith RJ; Thomas CP
    Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31738409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.
    Bansal V; Gassenhuber J; Phillips T; Oliveira G; Harbaugh R; Villarasa N; Topol EJ; Seufferlein T; Boehm BO
    BMC Med; 2017 Dec; 15(1):213. PubMed ID: 29207974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases.
    Bullich G; Domingo-Gallego A; Vargas I; Ruiz P; Lorente-Grandoso L; Furlano M; Fraga G; Madrid Á; Ariceta G; Borregán M; Piñero-Fernández JA; Rodríguez-Peña L; Ballesta-Martínez MJ; Llano-Rivas I; Meñica MA; Ballarín J; Torrents D; Torra R; Ars E
    Kidney Int; 2018 Aug; 94(2):363-371. PubMed ID: 29801666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies.
    Forleo C; D'Erchia AM; Sorrentino S; Manzari C; Chiara M; Iacoviello M; Guaricci AI; De Santis D; Musci RL; La Spada A; Marangelli V; Pesole G; Favale S
    PLoS One; 2017; 12(7):e0181842. PubMed ID: 28750076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of a targeted next generation sequencing panel in severe and pediatric onset Mendelian diseases.
    Isik E; Onay H; Atik T; Canda E; Cogulu O; Coker M; Ozkinay F
    Eur J Med Genet; 2019 Oct; 62(10):103725. PubMed ID: 31319225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical next generation sequencing in developmental and epileptic encephalopathies: Diagnostic relevance of data re-analysis and variants re-interpretation.
    Salinas V; Martínez N; Maturo JP; Rodriguez-Quiroga SA; Zavala L; Medina N; Amartino H; Sfaello I; Agosta G; Serafín EM; Morón DG; Kauffman MA; Vega P
    Eur J Med Genet; 2021 Dec; 64(12):104363. PubMed ID: 34673242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
    Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
    J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes.
    Travaglini L; Aiello C; Stregapede F; D'Amico A; Alesi V; Ciolfi A; Bruselles A; Catteruccia M; Pizzi S; Zanni G; Loddo S; Barresi S; Vasco G; Tartaglia M; Bertini E; Nicita F
    Neurogenetics; 2018 May; 19(2):111-121. PubMed ID: 29691679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.